Non-insulin Patch Pumps Market
Non-insulin Patch Pumps Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Non-insulin Patch Pumps Market Size and Growth
The Non-insulin Patch Pumps market is experiencing robust growth, driven by advancements in wearable technology and increasing demand for diabetes management solutions. The market size is projected to reach approximately USD 1.5 billion by 2026, reflecting a CAGR of over 15%. Emerging trends focus on enhanced user experience and connectivity features. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Ypsomed
◍ Amgen
◍ West Pharmaceuticals
◍ Unilife Corporation
◍ CeQur
◍ Sensile Medical
◍ BD Medical
◍ Enable Injections
◍ Sorrel Medical
◍ E3D Elcam Drug Delivery Devices
The non-insulin patch pumps market includes key players like Ypsomed, Amgen, and BD Medical, focusing on innovative drug delivery systems. Companies enhance market growth through advanced technology, partnerships, and extensive research. They target diverse therapeutic areas, driving adoption and sales. Notable sales revenues include Ypsomed ($250M) and BD Medical ($17B).
Request Sample Report
Market Segmentation
By Application
Hospitals ◍ Clinics ◍ Home Care Settings
Others
By Product
◍ On-Body Injectors ◍ Off-Body Injectors
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
